Patents by Inventor Claude Benedict

Claude Benedict has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 11913000
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: February 27, 2024
    Assignee: IVERIC bio, Inc.
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20210332361
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 12, 2021
    Publication date: October 28, 2021
    Applicant: ARCHEMIX LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 10947544
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: March 16, 2021
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20190185858
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 20, 2019
    Applicant: ARCHEMIX LLC
    Inventors: CLAUDE BENEDICT, DAVID EPSTEIN, CHARLES WILSON, DILARA MCCAULEY, JEFFREY KURZ, MARKUS KURZ, THOMAS GREENE MCCAULEY, JAMES ROTTMAN
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20180030446
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 2, 2017
    Publication date: February 1, 2018
    Applicant: ARCHEMIX LLC
    Inventors: Claude BENEDICT, David EPSTEIN, Charles WILSON, Dilara MCCAULEY, Jeffrey KURZ, Markus KURZ, Thomas Greene MCCAULEY, James ROTTMAN
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 9617546
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: April 11, 2017
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
    Publication number: 20150159158
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 11, 2015
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8946184
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: February 3, 2015
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20130237589
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 4, 2013
    Publication date: September 12, 2013
    Applicant: ARCHEMIX LLC
    Inventors: Claude BENEDICT, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8436164
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 7, 2013
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20120322860
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: ARCHEMIX LLC
    Inventors: CLAUDE BENEDICT, DAVID EPSTEIN, CHARLES WILSON, DILARA MCCAULEY, JEFFREY KURZ, MARKUS KURZ, THOMAS GREENE MCCAULEY, JAMES ROTTMAN
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8236773
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 7, 2012
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
    Patent number: 7998940
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: August 16, 2011
    Assignee: Archemix Corp.
    Inventors: John L. Diener, H. A. Daniel Lagasse, Claude Benedict
  • Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
    Publication number: 20110060027
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 14, 2006
    Publication date: March 10, 2011
    Inventor: Claude Benedict
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7803931
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: September 28, 2010
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
  • Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
    Patent number: 7589073
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: September 15, 2009
    Assignee: Archemix Corp.
    Inventors: John L. Diener, H. A. Daniel Lagassé, Claude Benedict
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7579456
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 25, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, David Epstein, Dilârâ McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Charles Wilson
  • Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
    Patent number: 7566701
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: July 28, 2009
    Assignee: Archemix Corp.
    Inventors: John L. Diener, H. A. Daniel Lagassé, Claude Benedict
  • Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
    Publication number: 20090149643
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor.
    Type: Application
    Filed: January 29, 2009
    Publication date: June 11, 2009
    Applicant: Archemix Corp.
    Inventors: John L. Diener, H.A. Daniel Lagasse, Claude Benedict
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7538211
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 26, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski